https://www.selleckchem.com/
The impact of BBR on neurological disorder using a transgenic AD type mouse strain (TgCRND8) showed a reduction in the piling up of amyloid-β plaque. In mice, administration of BBR in the dose range of 5-10m/kg has been reported to raise the levels of serotonin (47%), dopamine (31%), and norepinephrine (29%) in CNS to allay depression. The present review is aimed to summarize the potential of Berberine in the amelioration of various neurological disorders. The present review is aimed to summarize the potential of Berberine in the amelioration of various neu
Like
Comment
Share
